Feb 4 (Reuters) - AbbVie forecast 2026 profit above Wall Street estimates on Wednesday after posting a fourth-quarter results beat, fueled by strong demand for newer immunology drugs Skyrizi and ...

The data on Pfizer's GLP-1 offer early evidence that the injection can be administered less frequently than existing drugs ...

Injectable dermal products have become some of the most sought-after cosmetic treatments. But behind every injection lies a ...

Learn how to self-administer SCIg at home for primary immunodeficiency. Tips on preparation, reducing pain, managing ...

AbbVie extended the patent life on Humira for years, enough time to more than replace the sales. Now Merck and Bristol Myers ...

An electrifying Clásico awaits this Sunday in the Spanish Super Cup final between Real Madrid and FC Barcelona. Ahead of the showdown, much of the attention is focused on Kylian Mbappé, whose ...

Using same proprietary, patented technology, VIVI Med extends the product portfolio beyond injectable pens, opening access to broader patient populations, premium ...

New Afrezza prescribing information outlines higher starting dose conversions for patients transitioning from mealtime insulin to improve glycemic control.

GREENVILLE, S.C. and SACRAMENTO, Calif., Jan. 6, 2026 /PRNewswire/ -- PAI Pharma ("PAI"), a portfolio company of Olympus Partners and a leading U.S. developer, manufacturer and marketer of oral liquid ...

Using a dime-size amount of product, apply moisturizer in sweeping motions, starting from the middle of the face and moving ...

A University of Missouri researcher has unveiled a safer, smarter way to fight drug-resistant infections. Dr. Hongmin Sun, an ...

Turmeric and ibuprofen both reduce inflammation and pain, but they work in different ways. Learn how curcumin extract (from ...